All In Biotech

Drug Trial Radar · NCT01736033

Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) Patients

A Multicenter, Randomized, Double-blind, Clinical Study to Investigate the Efficacy and Safety of Treatment With Tamsulosin 0.2mg Mono and Tamsulosin 0.2mg, Finasteride 5mg Combination Therapy in Patients With LUTS/BPH

Last checked: Nov 19, 2026Latest source record: May 14, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 545 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

545

Actual

Start

Feb 2012

Primary completion

Feb 2017

Study completion Jun 2017

Sponsor

Lead sponsor
Seoul National University HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Astellas Pharma Korea, Inc.; Medical Research Collaborating Center, Seoul, Korea
First posted
Nov 29, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
Male only, from 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the clinical efficacy of alpha-blocker monotherapy and alpha-blocker + 5-alpha reductase inhibitor combination therapy in benign prostate hyperplasia patients, and suggest guidelines of the combination therapy.

Conditions

  • Benign Prostate Hyperplasia

Interventions

  • TamsulosinDrug

    1 tablet(0.2mg) orally q.d.

  • FinasterideDrug

    1 tablet(5mg) orally q.d.

  • PlaceboDrug

    1 tablet(0.2mg) orally q.d.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical ProgressionTime frame: 1 & 2 months after baseline, and then every 3 months up to 4 years

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • Pusan National University Hospital

    Busan, South Korea

  • Seoul National University Hospital

    Seoul, South Korea

  • Eulji General Hospital

    Seoul, South Korea

  • Soon Chun Hyang University Hospital Cheonan

    Cheonan, Chungcheongnam-do, South Korea

  • Hallym University Sacred Heart Hospital

    Anyang, Gyeoggi, South Korea

  • Bucheon St. Mary's Hospital

    Bucheon-si, Gyeonggi-do, South Korea

  • Soon Chun Hyang University Hospital Bucheon

    Bucheon-si, Gyeonggi-do, South Korea

  • Seoul National University Bundang Hospital

    Seongnam-si, Gyeonggi-do, South Korea

  • Ajou University Hospital

    Suwon, Gyeonggi-do, South Korea

  • Chonnam National University Hwasun Hospital

    Hwasun, Jeollanam-do, South Korea

  • Chungbuk National University Hospital

    Cheongju-si, North Chungcheong, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.